Frequency of HLA-A*03 associates with HIV-1 infection in a Chinese cohort by WeiLun Zhang et al.
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2013. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
*Corresponding author (email: zhengdx@pumc.edu.cn; yshao@public3.bta.net.cn) 
• RESEARCH  PAPER • November 2013  Vol.56  No.11: 1014–1019 
 doi: 10.1007/s11427-013-4555-4 
Frequency of HLA-A*03 associates with HIV-1 infection in a  
Chinese cohort 
ZHANG WeiLun1, WANG Li1, HONG KunXue2, LIU YanXin1, SU Bing3, XU Cheng4, 
XU JianQin2, RUAN YuHua2, SHAO YiMin2* & ZHENG DeXian1* 
1Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China; 
2State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, 
Beijing 100005, China; 
3Anhui Center for Disease Control and Prevention, Hefei 230601, China; 
4Fuyang Center for Disease Control and Prevention, Fuyang 236030, China 
Received March 19, 2012; accepted September 3, 2012; published online October 9, 2013 
 
During the early mid-1990s, a number of rural farmers across central China were employed to the unregulated plasma-    
selling-activity and many of them were infected by HIV-1. However, AIDS progression in the former blood donors (FBDs) is 
various. The aim of this study is to assess human leukocyte antigen (HLA) class I allele distribution in FBDs and evaluate its 
association with HIV-1 infection and disease progression. A total of 353 FBDs were enrolled in the cohort including 294 ART 
naïve HIV-1 seropositive and 59 HIV-1 seronegative age-matched subjects. The viral load and CD4/CD8 T cell counts were 
assessed in all subjects. Compared with HIV-seropositive group, the frequency of HLA-A*03 in control was significantly 
higher. After classifying the HLA-B alleles of the subjects according to the presence of Bw4/Bw6 serological epitopes, detri-
mental effect of HLA Bw6/ Bw6 homozygosity was also confirmed in the HIV-seropositive subjects. This study provides nov-
el evidence on HLA class I allele distribution and association of HLA-A*03 frequency with HIV-1 infection and viremia in the 
HIV-1 infected FBDs, which may throw light on intervention strategy for the HIV-1 infection and our understanding how host 
immunity and genetic background affect HIV infection and AIDS progression.  
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Human immunodeficiency virus (HIV) infection causes 
progressive damage to the immune system due to acquired 
immunodeficiency syndrome (AIDS). The majority (~80%) 
of individuals with HIV-infection have a mean of 8–10 
years’ latent infection and subsequently progress to clinical 
AIDS [1–4]. A proportion of HIV-1 infected individuals, 
designated as viremic controllers, continuously maintain 
HIV RNA levels below 2000 copies mL1 for at least one 
year without antiretroviral treatment. In addition, some 
HIV-positive individuals, often referred to as “elite control-
lers” or “aviremic controllers”, remain clinically healthy 
with HIV RNA levels below 50 copies mL1, and have a 
higher numbers of CD4+ T helper lymphocytes and cyto-
toxic T lymphocytes (CTLs) than either viremic controllers 
or noncontrollers [5–8]. The relative threshold of plasma 
HIV RNA levels at or below 2000 copies mL1 is important 
since Gray et al. [9] reported that the risk of HIV transmis-
sion was markedly reduced and the progression of disease 
was mild at these HIV RNA levels. Currently there is no 
available vaccine to prevent HIV-1 infection; thus, devel-
oping a vaccine to suppress viremia in HIV-positive indi-
viduals is critical to prevent the spread of HIV infection.  
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The mechanism of protection against HIV-1 infection 
and long-term control of viremia in HIV controllers is not 
well understood, but may be multifactorial [10–13]. The 
human leukocyte antigen (HLA) system plays a crucial role 
in initiating innate and adaptive immune responses, there-
fore HLA genetic variance may be an important cofactor of 
HIV infection [14,15], and elucidating the interactions be-
tween HLA and HIV may help vaccine research. During 
HIV infection, HLA class I gene products bind and present 
pathogen-derived peptides from infected cells to form stable 
HLA molecule/virus peptide complexes. CD8+ CTLs that 
recognize their cognate antigen in the context of HLA class I 
are activated and lyse the infected cells [1618]. In addition, 
killer immunoglobulin-like receptors or killer cell inhibitory 
receptors (KIRs) expressed by nature killer (NK) cells recog-
nize groups of HLA class I alleles. Interactions between KIRs 
and HLA class I allele products prohibit the activity of NK 
cells and affect host innate defense to HIV. Thus, there have 
been continued attempts to correlate HLA gene polymor-
phisms with HIV-1 infection and disease progression [19].  
During the early mid-1990s, a number of rural farmers 
across central China were involved in the selling of unregu-
lated plasma and many of them were infected by the same 
clade of HIV-1 B′. However, AIDS progression in the for-
mer blood donors (FBDs) was different, and the correlation 
between host immunity and HIV-1 infection and disease 
progression is not well understood. In the present study, we 
examined the association of HLA alleles with HIV-1 infec-
tion and disease progression in a HIV-1 positive FBD cohort 
from Fuyang County, Anhui Province, China. HIV positive 
FBDs (n=294) and HIV negative blood donors (n=59) were 
enrolled in the study. The aim of this study was to understand 
how host immunity and genetic background affects disease 
progression in a Chinese FBD cohort. 
1  Materials and methods 
1.1  Study population 
A total of 353 subjects enrolled in this study were rural 
farmers who had a history of unregulated commercial plas-
ma donation in Fuyang County, Anhui Province, China be-
tween 1992 and 1995. Among the donors, 294 were anti-    
retrovirus therapy (ART) naïve HIV-1 seropositive FBDs, 
who were infected with HIV-1 B′ clade by either contami-
nated blood collection equipment or the re-infusion of 
pooled buffy coats, and 59 were HIV-1 seronegative 
age-matched FBDs for controls. The HIV-1 positive group 
was divided into two subgroups, a viremic controller group 
and a noncontroller group, according to the criteria devel-
oped by the International HIV Controller Consortium. The 
viremic controllers are asymptomatic FBDs who had been 
tested seropositive with HIV RNA <2000 copies mL1 and 
with no antiretroviral treatment, and the plasma HIV RNA 
level must have been maintained at least one year by three 
determinations. The rest of HIV-positive FBDs were de-
fined as noncontrollers. All subjects were fully informed of 
the comprehensive process and the purpose of the research 
before signing an informed consent in the local language. 
The informed consent forms and all protocols were re-
viewed by the Institutional Review Board, Chinese National 
Center for AIDS/STD Prevention and Control, and Division 
of AIDS Prevention Science Review Committee, Anhui 
Provincial Center for Disease Prevention and Control.   
1.2  Immunological and virological measurements 
CD4+ T cells were measured by single-platform flow cy-
tometry (FACSCanto, BD, San Jose, CA, USA). Plasma 
HIV-1 RNA levels were measured by the COBAS Am-
plicor™ HIV-1 Monitor Test, v1.5 (Roche Diagnostics, 
Shanghai, China) according to the manufacturer’s instruc-
tions. HIV-1 RNA levels transformed to lg were treated as a 
continuous variable in separate analysis. 
1.3  DNA extraction and HLA class I typing 
High-molecular-weight genomic DNA was extracted from 
EDTA anti-coagulated whole blood using a QIAamp DNA 
Mini kit (Qiagen, Valencia, CA, USA) following the manu-
facturer’s manual. All DNA samples were stored at 20°C 
in Tris-EDTA bsuffer (10 mmol L1 Tris-Cl, 0.5 mmol L1 
EDTA, pH 9.0). HLA class I genotyping was performed 
using polymerase chain reaction sequence-specified primers 
(PCR-SSPs) and commercial PCR-SSP kits (Texas Biogene, 
Shanghai, China).  
1.4  Statistical analysis  
Baseline characteristics of differences among HIV-1 nega-
tive, positive, viremic controllers and noncontrollers were 
compared by analysis of variance (ANOVA) for age, lg- 
transformed-viral loads and CD4+ cell counts and a Chi- 
square test, when appropriate, for categorical variables. The 
association between an HLA alleles and infection was de-
scribed by the odds ratio (OR) and 95% confidence interval 
(CI), which was calculated according to Woof’s formula or 
Haldane’s modification of the formula [20]. P-values were 
determined by Chi-square analysis or by Fisher’s exact test 
and a P-value less than 0.05 was considered statistically sig-
nificant. All analyses were performed with Statistical Analy-
sis System (version 9.13, SAS Institute, Cary, NC, USA).  
2  Results 
2.1  Description of the study cohort 
The characteristics of 353 individuals in the cohort are 
shown in Table 1. The median ages of the HIV-1 negative,  
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HIV-1 positive, controllers and noncontrollers groups were 
44.4±8.3, 42.4±7.9, 40.7±6.2 and 42.8±8.2 years, respec-
tively. There was no significant difference in age (P=0.088) 
or gender (P=0.826) between the HIV-1 negative group and 
positive group. The CD4+ T cell counts of HIV-1 negative 
and positive groups were 665±230 and 335±179, respec-
tively (P<0.001), while those of controller and noncontrol-
ler groups were 444±115 and 320±183, respectively. The 
median viral loads were 4.68±0.69 lg copies mm3 in non-
controllers and 2.75±0.23 lg copies mm3 in viremic con-
trollers. 
2.2  Distribution of major HLA class I variants in FBDs 
Distribution analysis of major HLA class I variants in the 
FBDs was performed using two-digit allele designation. As 
shown in Table 2, at the two-digit specificity level, 16 dif-
ferent HLA-A, 27 HLA-B and 13 HLA-Cw variants were 
observed in the HIV-1 positive group, and nine different 
HLA-A, 20 HLA-B and 11 HLA-Cw variants in HIV-1 nega-
tive group. Twelve HLA class I alleles occurred at a fre-
quency greater than 10% amongst HIV-1 positive subjects as 
follows: HLA-A*02 (32.99%), HLA-A*11 (15.14%), 
HLA-A*24 (19.73%), HLA-A*30 (14.97%), HLA-B*13  
Table 1  Basic information of the subject cohorta) 
Attribute 




HIV-1 positive group (n=288)* 
Noncontrollers (n=251) Viremic controllers (n=37) 
Gender (male/female) 30/29 157/137 137/114 16/21 
Age (year) 44.4±8.3 42.4±7.9 42.8±8.2 40.7±6.2 
CD4+ T cells mm3  665±230 335±179 444±115 320±183 
Viral load (RNA copies mL) 








a) n, the number of FBDs; *, six FBDs were not followed up. 
Table 2  Frequencies of human leukocyte antigen alleles in FBDsa) 
Allele 
HIV-1 positive group 
(2n=588)  
HIV-1 negative group 
(2n=118) Allele 
HIV-1 positive group 
(2n=588)  
 
HIV-1 negative group 
(2n=118) 
N f (%) N f (%) N f (%) N f (%) 
A*01 8 1.36  3 2.54 B*07 27 4.59  4 3.39 
A*02 194 32.99  43 36.44 B*08 2 0.34  2 1.69 
A*03 23 3.91  11 9.32 B*13 93 15.82  9 7.63 
A*11 89 15.14  10 8.47 B*14 2 0.34  n/a n/a 
A*23 1 0.17  n/a n/a B*15 80 13.61  21 17.80 
A*24 116 19.73  29 24.58 B*18 n/a n/a  5 4.24 
A*26 10 1.70  2 1.69 B*21 1 0.17  n/a n/a 
A*29 7 1.19  n/a n/a B*27 14 2.38  n/a n/a 
A*30 88 14.97  14 11.86 B*35 33 5.61  3 2.54 
A*31 11 1.87  n/a n/a B*37 4 0.68  2 1.69 
A*32 8 1.36  n/a n/a B*38 14 2.38  n/a n/a 
A*33 22 3.74  5 4.24 B*39 6 1.02  3 2.54 
A*36 1 0.17  n/a n/a B*40 79 13.44  19 16.10 
A*66 1 0.17  n/a n/a B*42 1 0.17  n/a n/a 
A*68 7 1.19  1 0.85 B*44 27 4.59  9 7.63 
A*69 2 0.34  n/a n/a B*45 2 0.34  n/a n/a 
      B*46 31 5.27  5 4.24 
Cw*01 73 12.41  14 11.86 B*48 16 2.72  6 5.08 
Cw*02 8 1.36  n/a n/a B*50 4 0.68  n/a n/a 
Cw*03 103 17.52  31 26.27 B*51 61 10.37  11 9.32 
Cw*04 46 7.82  5 4.24 B*52 21 3.57  n/a n/a 
Cw*05 7 1.19  2 1.69 B*54 14 2.38  3 2.54 
Cw*06 93 15.82  9 7.63 B*55 15 2.55  3 2.54 
Cw*07 37 6.29  11 9.32 B*56 n/a n/a  1 0.85 
Cw*08 82 13.95  20 16.95 B*57 2 0.34  1 0.85 
Cw*12 45 7.65  8 6.78 B*58 32 5.44  9 7.63 
Cw*14 38 6.46  11 9.32 B*59 2 0.34  n/a n/a 
Cw*15 50 8.50  5 4.24 B*67 4 0.68  1 0.85 
Cw*16 5 0.85  2 1.69 B*78 n/a n/a  1 0.85 
Cw*18 1 0.17  n/a n/a B*81 1 0.17  n/a n/a 
a) 2n, the number of chromosomes as each gene has two chromosomes; N, the subject number; f, the frequency; n/a, not available.  
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(15.82%), HLA-B*15 (13.61%), HLA-B*40 (13.44%), 
HLA-B*51 (10.37%), HLA-Cw*01 (12.41%), HLA-Cw*03 
(17.52%), HLA-Cw*06 (15.82%), and HLA-Cw*08 
(13.95%). The predominant HLA class I alleles (>10%) in 
the HIV-1 negative group were HLA-A*02 (36.44%), 
HLA-A*24 (24.58%), HLA-A*30 (11.86%), HLA-B*15 
(17.80%), HLA-B*40 (16.10%), HLA-Cw*01 (11.86%), 
HLA-Cw*03 (26.27%) and HLA-Cw*08 (16.95%).  
2.3  Association of HLA class I alleles with HIV-1 in-
fection and viremic control 
Association of HLA allele distribution with the susceptibi-    
lity/resistance to HIV infection was evaluated by comparing 
the frequencies of HLA-A, -B, and -Cw in the HIV-1 posi-
tive group with those in the negative group. As shown in 
Table 3, the frequency of HLA-A*03 and Cw*03 in the 
negative group was more prevalent than in the positive 
group with OR=0.4 (95% CI: 0.19–0.84, P=0.012) and 0.6 
(95% CI: 0.38–0.95, P=0.028), respectively. However, the-
se data did not achieve statistical significance after correc-
tion. To further reveal the correlation of virus replication 
controlling with HLA class I alleles, we analyzed the dis-
tribution of HLA class I allele in 37 viremic controllers and 
251 noncontrollers. The results showed that 12.16% of con-
trollers were HLA-A*03 positive compared to 2.39% of 
noncontrollers (Table 4, P<0.0001), suggesting that HLA- 
A*03 plays an important role in HIV infection and might be 
a protective allele.  
2.4  Association of HLA-Bw6 homozygosity with dis-
ease progression 
All HLA-B alleles can be categorized by the presence of 
Bw4 or Bw6 epitopes. According to the “HLA geno-
type/serotype dictionary” (http://www.anthonynolan.org.uk/ 
HIG/lists/bsplit. html), the HLA-B allele is converted into a 
serologic equivalent of each genotype and sorted into Bw4 
or Bw6 groups. As shown in Table 5, using the “Bw4 and 
Bw6 associated specificity file”, three groups were Bw4/ 
Bw4, Bw4/Bw6, and Bw6/Bw6. Among all HIV-1-infected 
individuals, the Bw6/Bw6 homozygote was lower in the 
viremic controller group than that in the noncontroller group. 
There were 5/37 Bw6/Bw6 homozygotes in the controller 
group and 80/251 in the noncontroller group (P=0.022), in 
which the Bw4/Bw4 and Bw6/Bw4 frequencies were slig- 
htly higher. There were 50 Bw4/Bw4 homozygotes in 251 
noncontrollers and 10 Bw4/Bw4 homozygotes in 37 con-
trollers. These data suggest that the Bw6/Bw6 homozygote 
might be associated with poor virologic control in the Chi-
nese HIV-infected population.  
3  Discussion 
HIV/AIDS is a leading cause of infectious disease mortality 
worldwide. Many intensive studies have been designed to 
identify factors relating to HIV infection and durable HIV 
control. The correlation between HIV/AIDS and HLA al-
leles is complicated and often affected by confounding fac-
tors. Factors such as populations with different genetic 
backgrounds, frequency of the allele, methods of HLA typ-
ing and standard clinic appraisal can distort allele associa-
tion with HIV and lead to research bias.  
Illegal commercial blood collection began in 1992, and 
was prevalent among farmers from Fuyang County, Anhui 
Province, China. HIV infection testing started in 1993, and 
no HIV infection in the FBDs was reported in this area until  
Table 3  Distribution of HLA-A*03, HLA-B*13, HLA-Cw*03, and HLA-Cw*06 in HIV-positive and -negative group 
 HIV-positive individual 
 
Control 
P OR 95% CI 
 Subject number Gene frequency (%) Subject number Gene frequency (%) 
A*03 23 3.91  11 9.32 0.012 0.40 0.19–0.84 
B*13 93 15.82  9 7.63 0.024 2.28 1.11–4.65 
Cw*03 103 17.52  31 26.27 0.028 0.60 0.38–0.95 
Cw*06 93 15.82  9 7.63 0.024 2.28 1.11–4.65 





P OR 95% CI 
Allele Frequency (%) Allele Frequency (%) 
A*03 12 2.39  9 12.16 <0.001 0.18 0.070.44 
Table 5  HLA-Bw4 and HLA-Bw6 genotype in viremic controllers and noncontrollersa) 
HLA n Bw4/Bw4 f P Bw6/Bw4 f P Bw6/Bw6 f P Bw4(f) Bw6(f) P 
Controllers 37 10 0.27  22 0.595  5 0.135  0.568 0.432  
Noncontrollers 251 50 0.199 0.32 121 0.482 0.20 80 0.318 0.022 0.44 0.56 0.147 
a) f, gene frequency. 
A * 3 6
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1995. It is likely that HIV-1 infection spreads among com-
mercial blood donors at that time due to contaminated blood 
collection equipment or the re-infusion of pooled buffy coat. 
Often, individuals may have participated in more than one 
blood donation group, resulting in virus spreading to the 
whole FBD population during a short period. The molecu-
lar-epidemiologic data showed that the FBD individuals 
were infected by the same virus, HIV-1 B′ clade, and that 
the genetic distance among the isolates from this area was 
limited [19,21]. In the present study, we selected FBDs who 
were ethnically identical and infected in a narrow-window 
of time with a homogenous HIV strain to explore the corre-
lation of HIV infection and disease progression with the 
host HLA allele distribution.  
We have identified 12 HLA class I alleles that were pre-
sent in more than 10% of HIV-infected subjects and 9 HLA 
class I alleles in the controls. HLA-A*03 and HLA-Cw*03 
alleles occurred more frequently in the control group than 
those in the infected group, whereas B*13 and Cw*06 were 
relatively enriched in HIV-positive subjects. HLA-B*13, 
Cw*03 and Cw*06 were more common alleles in the study 
cohort, while HLA-A*03 was rare or infrequent. Though 
the P-value of the four alleles did not reach significant dif-
ference after correction, it suggests a potential trend of al-
lele distribution with susceptibility or resistance to HIV-1 
infection.  
To investigate the correlation of HLA with virus control, 
we subgrouped HIV-1 infected individuals according to the 
criteria of the HIV Controller Consortium. The distribution 
frequency of HLA-A*03 was significantly higher in the 
controls (P<0.001, OR=0.18, 95% CI=0.07–0.44), suggest-
ing that HLA-A*03 might be a protective factor for HIV-1 
infection and disease progression. We further explored the 
relationship between the HLA-A loci and virus load (VL) 
and demonstrated that the median VL of HLA-A*03 was 
markedly lower in the HIV infected group compared with 
that of other HLA-A alleles (Figure 1). With VL increase, 
the number of HLA-A*03 individuals markedly decreased, 
whereas carriers of other alleles were normally distributed 
(Figure 2). Zhai et al. [22] reported that HLA-B35 and 
HLA-A03 significantly contributed to the total virus-      
specific CTL responses in Chinese populations. Our data 
provided further evidence for a potential protective role of 
HLA-A*03 in HIV infection and virus control in the Chi-
nese population. However, our results do not replicate the 
report by Gao et al. [23] where HLA-B*57 was a protective 
factor against HIV infection, and HLA-B*35 was a suscep-
tible factor in a Caucasian population, or a report by Li et al. 
[24] where HLA-B*44 and HLA-Cw*04 alleles were sig-
nificantly enriched in HIV-1-seronegative controls in a coh- 
 
 
Figure 1  Contributions of HLA-A loci to viral load variation. Viral loads of different HLA-A alleles are shown as box plots, bold lines in boxes indicate 
median viral load of different alleles. Vertical lines indicate cohort median viral load. 
 
Figure 2  Distributions of HLA-A*03 and other alleles in different viral RNA load. HIV-1 infected individuals were grouped by viral RNA load. 
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ort of Chinese. This suggests that putative disease alleles 
play diverse roles in different ethnic populations. Further-
more, the number of HIV-negative FBDs in this study was 
limited compared with the infected subjects. Taking into 
account a large number of HLA-A3-restricted HIV-1 
epitopes have been reported and the mechanism of T cell 
receptor cross-recognition of these epitopes has been thor-
oughly examined [25,26], the potential protective function 
of HLA-A*03 is worthy of further study.  
Pedro et al. [27] reported that KIRs were essential for 
NK cells to identify “missing-self” and activate innate im-
munity against viruses. Only the Bw4 molecule is a ligand 
for NK cell KIRs, so the profound suppression of HIV-1 
viremia may be associated with HLA-Bw4 homozygotes. 
Qing et al. [28] reported that HLA-Bw6 homozygosity had 
an accelerating effect on Chinese HIV-1-infected patients. 
In agreement with their report, the HLA-Bw6 homozygote 
was strongly associated with poor HIV control of the HIV- 
infected FBDs in the present study. 
In summary, this study provides novel evidence on HLA 
class I allele distribution and association of HLA-A*03 
frequency with HIV-1 infection and viremia in the clade of 
HIV-1 B′ infected FBDs. This may help develop an inter-
vention strategy for the HIV-1 infected Chinese population 
and our understanding of how host immunity and genetic 
backgrounds affect HIV infection and AIDS progression. 
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